Business1 Min Read SidonApril 20, 2026 Eris reports problems identified at Swiss Parenterals facilities; expected effect appears limited. Eris Lifesciences encounters non-compliance observations from HALMED at its Swiss Parenterals facilities in Ahmedabad, with plans for GMP…
